HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tibial hemimelia in Langer-Giedion syndrome with 8q23.1-q24.12 interstitial deletion.

Abstract
Langer-Giedion syndrome (LGS) (OMIM 150230) is defined as a contiguous gene syndrome caused by loss of functional copies of the TRPS1 and EXT1 genes usually secondary to 8q microdeletion. Tibial hemimelia (TH) is the least common lower limb deficiency characterized by hypoplasia of the tibia with relatively intact fibula. We describe the third report of LGS with bilateral TH and an 8q23.1-q24.12 interstitial deletion. It is not possible to exclude that this association is fortuitous, but our report reinforces the suggestion of a putative gene involved in limb development in this chromosomal region interval.
AuthorsDaniel Rocha Carvalho, Savana Camilla Lima Santos, Maria Dulce Valverde Oliveira, Carlos Eduardo Speck-Martins
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 155A Issue 11 Pg. 2784-7 (Nov 2011) ISSN: 1552-4833 [Electronic] United States
PMID21948702 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Wiley Periodicals, Inc.
Chemical References
  • DNA-Binding Proteins
  • Repressor Proteins
  • TRPS1 protein, human
  • Transcription Factors
  • N-Acetylglucosaminyltransferases
  • exostosin-1
Topics
  • Abnormal Karyotype
  • Adolescent
  • Bone Diseases, Developmental (diagnostic imaging, genetics, pathology)
  • Child, Preschool
  • Chromosome Deletion
  • Chromosomes, Human, Pair 8 (genetics)
  • DNA-Binding Proteins (genetics)
  • Ectromelia (diagnostic imaging, genetics, pathology)
  • Humans
  • Langer-Giedion Syndrome (genetics, pathology)
  • Male
  • N-Acetylglucosaminyltransferases (genetics)
  • Radiography
  • Repressor Proteins
  • Tibia (abnormalities, diagnostic imaging, pathology)
  • Transcription Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: